BULLFROG AI HOLDINGS, INC. Accrued Liabilities, Current
BULLFROG AI HOLDINGS, INC. (BFRG) had Accrued Liabilities, Current of $446.51 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $446.51K.
- 2026-03-31: Accrued Liabilities, Current $301.20K.
- 2025-12-31: Accrued Liabilities, Current $503.87K.
- 2025-09-30: Accrued Liabilities, Current $534.88K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $446.51K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $301.20K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $503.87K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $534.88K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $363.92K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $464.79K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $152.16K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $515.66K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $268.44K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $182.83K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $80.69K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $122.26K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $195.90K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $310.89K 10-Q · filed 2023-05-24 | |
| 2022-12-31 | $982.99K 10-K · filed 2024-03-29 | $416.07K 10-K · filed 2023-04-25 |
| 2021-12-31 | $68.56K 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |